Literature DB >> 15741219

Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.

Alexander Röth1, Gabriela M Baerlocher, Mike Schertzer, Elizabeth Chavez, Ulrich Dührsen, Peter M Lansdorp.   

Abstract

Little is known about the long-term consequences of overexpression of the human telomerase reverse transcriptase (hTERT) gene in T lymphocytes. To address this issue, we transduced polyclonal as well as clonally derived populations of naive and memory CD44 T cells from 2 healthy donors (aged 24 and 34 years) with retroviral vectors encoding green fluorescence protein (GFP) and hTERT (GFP-hTERT) or GFP alone. After transduction, cells were sorted on the basis of GFP expression and cultured in vitro until senescence. T cells transduced with hTERT exhibited high stable telomerase activity throughout the culture period. Relative to GFP controls, minor changes in overall gene expression were observed yet the proliferative lifespan of the hTERT-transduced populations was significantly increased and the rate of telomere loss was lower. Nevertheless, hTERT-transduced cells showed progressive telomere loss and had shorter telomeres at senescence than controls (2.3 +/- 0.3 kilobase [kb] versus 3.4 +/- 0.1 kb). Furthermore, a population of cells with 4N DNA consisting of binucleated cells with connected nuclei emerged in the hTERT-transduced cells prior to senescence. We conclude that overexpression of hTERT in CD4+ T cells provides a proliferative advantage independent of the average telomere length but does not prevent eventual genetic instability and replicative senescence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741219      PMCID: PMC1895130          DOI: 10.1182/blood-2004-10-4144

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I.

Authors:  Juan I Young; John M Sedivy; James R Smith
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

2.  A DNA damage checkpoint response in telomere-initiated senescence.

Authors:  Fabrizio d'Adda di Fagagna; Philip M Reaper; Lorena Clay-Farrace; Heike Fiegler; Philippa Carr; Thomas Von Zglinicki; Gabriele Saretzki; Nigel P Carter; Stephen P Jackson
Journal:  Nature       Date:  2003-11-05       Impact factor: 49.962

Review 3.  Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Authors:  Christopher Baum; Christof von Kalle; Frank J T Staal; Zhixiong Li; Boris Fehse; Manfred Schmidt; Floor Weerkamp; Stefan Karlsson; Gerard Wagemaker; David A Williams
Journal:  Mol Ther       Date:  2004-01       Impact factor: 11.454

4.  Telomerase maintains telomere structure in normal human cells.

Authors:  Kenkichi Masutomi; Evan Y Yu; Shilagardy Khurts; Ittai Ben-Porath; Jennifer L Currier; Geoffrey B Metz; Mary W Brooks; Shuichi Kaneko; Seishi Murakami; James A DeCaprio; Robert A Weinberg; Sheila A Stewart; William C Hahn
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

5.  Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH.

Authors:  Gabriela M Baerlocher; Peter M Lansdorp
Journal:  Cytometry A       Date:  2003-09       Impact factor: 4.355

6.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

Authors:  X Zhang; V Mar; W Zhou; L Harrington; M O Robinson
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

7.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

8.  Telomerase is limiting the growth of acute myeloid leukemia cells.

Authors:  A Röth; S Vercauteren; H J Sutherland; P M Lansdorp
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

Review 9.  Regulation of telomerase by telomeric proteins.

Authors:  Agata Smogorzewska; Titia de Lange
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

10.  Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo.

Authors:  John R Reed; Milica Vukmanovic-Stejic; Jean M Fletcher; Maria Vieira D Soares; Joanne E Cook; Catherine H Orteu; Sarah E Jackson; Katie E Birch; Graham R Foster; Mike Salmon; Peter C L Beverley; Malcolm H A Rustin; Arne N Akbar
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  12 in total

1.  Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells.

Authors:  J C Y Wang; J K Warner; N Erdmann; P M Lansdorp; L Harrington; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

2.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

3.  An antiapoptotic role for telomerase RNA in human immune cells independent of telomere integrity or telomerase enzymatic activity.

Authors:  Francesca S Gazzaniga; Elizabeth H Blackburn
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

Review 4.  Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.

Authors:  Eugene V Barsov
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

Review 5.  Cellular lifespan and regenerative medicine.

Authors:  Thomas Petersen; Laura Niklason
Journal:  Biomaterials       Date:  2007-05-25       Impact factor: 12.479

Review 6.  Principles of adoptive T cell cancer therapy.

Authors:  Carl H June
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Replicative potential of human natural killer cells.

Authors:  Hiroyuki Fujisaki; Harumi Kakuda; Chihaya Imai; Charles G Mullighan; Dario Campana
Journal:  Br J Haematol       Date:  2009-03-26       Impact factor: 6.998

8.  Telomerase insufficiency in rheumatoid arthritis.

Authors:  Hiroshi Fujii; Lan Shao; Inés Colmegna; Jörg J Goronzy; Cornelia M Weyand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

9.  Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles.

Authors:  Sharon Aviran; Priya S Shah; David V Schaffer; Adam P Arkin
Journal:  PLoS Comput Biol       Date:  2010-08-12       Impact factor: 4.475

10.  p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells.

Authors:  Sian M Henson; Alessio Lanna; Natalie E Riddell; Ornella Franzese; Richard Macaulay; Stephen J Griffiths; Daniel J Puleston; Alexander Scarth Watson; Anna Katharina Simon; Sharon A Tooze; Arne N Akbar
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.